We also illustrated its anti-RA activity in AIA model rats, in which Ya-s11 inhibited TNF-α cathepsin K, TRAP, and MMP-9 expression and decreased the major features of RA pathogenesis. Here, ACP5 is linked to rheumatoid arthritis.